Purpose: The purpose of this study was to investigate the ability of a lactic-citric acid (LCA) blend and SLS to control the growth of Shiga toxin-producing Escherichia coli (STEC) in a broth system.
Methods: Rifampicin-resistant E. coli O157:H7 and a cocktail of non-O157:H7 strains were evaluated separately (8.0 log CFU/g). A blend solution of LCA at concentrations of 1%, 2%, and 2.4% and SLS at concentrations of 0.05%, 0.25%, and 0.5% were evaluated individually and in combination. A set of samples were inoculated with E. coli O157:H7 while another set was inoculated with a cocktail of non-O157:H7 strains (O26, O45, O103, O11, O121, O145, O104:H4). Samples were stomached and plated onto Sorbitol MacConkey agar infused with rifampicin (100 µg/ml) and incubated at 37°C for 24 h. Three replications were conducted.
Results: The ANOVA showed no individual effects (P > 0.05) of the LCA blend or SLS on the control of O157:H7 and the non-O157:H7 cocktail in the BHI broth. Applying the combined SLS (0.05% and 0.5%)) and LCA blend (2.4%) in the broth significantly (P < 0.01) reduced the non-O157:H7 by 5 log CFU/g and 2.9 and 4.6 log CFU/g in O157:H7 strains. Increasing the SLS concentration (0.25%) in LCA blend (2.4%) was more effective (P < 0.01) on O157:H7, showing 5 log CFU/g reduction.
Significance: This work will assist with providing new information on enhancing the wettability and the exposure of pathogens to antimicrobial treatment.